סינגולייר 4 מ"ג גרנולות לקטנטנים

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

MONTELUKAST AS SODIUM 4 MG

Disponibbli minn:

MERCK SHARP & DOHME ISRAEL LTD

Kodiċi ATC:

R03DC03

Għamla farmaċewtika:

GRANULES

Rotta amministrattiva:

PER OS

Manifatturat minn:

MERCK SHARP & DOHME, NETHERLANDS

Grupp terapewtiku:

MONTELUKAST

Indikazzjonijiet terapewtiċi:

Singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treament of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitatly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.

Data ta 'l-awtorizzazzjoni:

2009-01-01